Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 * "2+10" Design

Jan.07.2025
Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 * "2+10" Design
UK introduces new Bloody Bar 30K Triple Twist e-cigarette with unique pod design and multiple flavor options.

Special announcement:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are for descriptive purposes only and are not intended as advertisements for any products.

This article is prohibited for minors to access.


 

UK e-cigarette market have launched a new e-cigarette - the Bloody Bar 30K Triple Twist. This product features a unique design that combines 3 "2+10" combinations, offering triple flavors and 30,000 puffs.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Translation: Bloody Bar 30K Triple Twist|Image source: goldenvape

 

 

Specifically, the product specifications of the Bloody Bar 30K Triple Twist are as shown in the table below.

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Bloody Bar 30K Triple Twist Parameters | Design: 2Firsts

The key feature of the Bloody Bar 30K Triple Twist is its unique pod design. This e-cigarette device comes with three "2+10" pods, each with a total e-liquid capacity of 36 milliliters. Additionally, each pod can be filled with a different e-liquid flavor, allowing for quick flavor changes through a rotating mechanism.

 

Previously, Bloody Bar released a 2-in-1 e-cigarette called the Bloody Bar Ultra Twist 20K, which is capable of providing two different flavors at the same time. Users can easily switch between flavors by rotating the mouthpiece.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Public Notice | Image Source: MHRA

 

It is worth noting that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) e-cigarette notification system shows that "BLOODY BAR TRIPLE TWIST 30K" was publicly announced in November 2024. The applicant is BOWMAN SPECIALISED LIQUIDS LIMITED, founded by Christopher Bowman in 2012, a company focused on research and sales of e-cigarette e-liquids.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
BOWMAN SPECIALISED LIQUIDS LIMITED Website | Image source: BOWMAN

 

Currently, the Bloody Bar 30K Triple Twist has been listed on various UK e-cigarette distributor websites such as vapesourcing, ecigone, and vapeuk, with a price of approximately £12.99. However, the product has not yet been made available for sale on the company's official website.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Blood Bar 30K Triple Twist | Image source: vapesourcing

 


2Firsts will continue to monitor the performance and market trends of e-cigarette products globally, providing accurate and authoritative industry information to the public.

 

2FIRSTS, a product column, is dedicated to providing readers with the latest information on new products in the tobacco industry. To gather and share first-hand industry information more widely, 2FIRSTS welcomes readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us anytime via email at info@2firsts.com.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK reminds vaping firms to apply for new excise duty registration from April 2026
UK reminds vaping firms to apply for new excise duty registration from April 2026
HMRC has issued a reminder urging vaping manufacturers, importers and warehouse operators to prepare for registration under the UK’s new Vaping Products Duty, with applications opening in April 2026 and the duty taking effect in October.
Feb.10
Russia dismantles illegal vape liquid plant near Moscow; goods worth about $13 million seized
Russia dismantles illegal vape liquid plant near Moscow; goods worth about $13 million seized
Russian authorities say they have dismantled an illegal vape-liquid production site in the Moscow region, seizing four production lines, large quantities of components and finished goods, and substantial cash. The Interior Ministry estimated the seized products’ value at about 1 billion rubles (≈$13 million) and said the operation ran around the clock, producing up to 75,000 units per shift.
Feb.10 by 2FIRSTS.ai
Al Fakher Enters the Oral Nicotine Market With Four Flavors
Al Fakher Enters the Oral Nicotine Market With Four Flavors
Al Fakher has launched nicotine pouches, marking the world’s leading hookah brand’s entry into the modern oral nicotine category.
Apr.01 by 2FIRSTS.ai
NYC makers turn discarded disposable vapes into “Vape Synth” mini digital instruments
NYC makers turn discarded disposable vapes into “Vape Synth” mini digital instruments
The report says disposable vapes are sold at more than 11 million units per month and often end up in landfills after flavored nicotine juice runs out, along with lithium-ion batteries, microcontrollers, and LEDs, increasing the risk of waste fires. A New York City maker trio known as Paper Bag Team has built “Vape Synth” by cracking open spent Elf Bar cartridges—specifically the EB BC5000—and hacking them into tiny digital instruments.
Feb.12 by 2FIRSTS.ai
South Africa health department agrees to exempt smokeless and non-combustible products from tobacco control bill
South Africa health department agrees to exempt smokeless and non-combustible products from tobacco control bill
At a parliamentary committee meeting in South Africa, Health Minister Aaron Motsoaledi said the health department has agreed to exempt non-combustible and smokeless products — including chewing tobacco, snus, nicotine pouches and e-cigarettes — from the Tobacco Products and Electronic Delivery Systems Control Bill. The department is prepared, at this stage, to exempt them from packaging and labelling requirements except for misleading or false claims.
Mar.06 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24